Point72 Asia (Singapore)’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,659	Closed	-$69.9K	–	859
2025 Q1	$69.9K	Sell	45,659 -2,528	-5%	-$3.87K	0.02%	497
2024 Q4	$120K	Sell	48,187 -3,865	-7%	-$9.59K	0.03%	334
2024 Q3	$59.9K	Sell	52,052 -55,877	-52%	-$64.3K	0.01%	655
2024 Q2	$119K	Buy	+107,929	New	+$119K	0.02%	438